Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paltusotine in carcinoid syndrome
2024-511922-30-00Phase 2Completed
- Sponsor
- Crinetics Pharmaceuticals
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 2, randomised trial of paltusotine in Carcinoid Syndrome (CS) (2 arms), sponsored by Crinetics Pharmaceuticals. Primary endpoints: Safety and Pharmacokinetics. Started Aug 2024; status: completed.
02
Drugs
paltusotine
03
Conditions
Carcinoid Syndrome (CS)
Beyond the preview
Go deeper on 2024-511922-30-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511922-30-00.